naltrexone and Carcinogenesis

naltrexone has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Feng, Y; Liu, N; Ma, M; Shan, F; Wang, X	1

Other Studies

1 other study(ies) available for naltrexone and Carcinogenesis

Article	Year
Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway. International immunopharmacology, 2020, Volume: 83 Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinogenesis; Caspase 3; Cell Differentiation; Colorectal Neoplasms; Cytokines; Disease Progression; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Macrophages; Mice; Mice, Nude; Naltrexone; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Opioid; Signal Transduction; Th1 Cells	2020

Article

Year

Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.

International immunopharmacology, 2020, Volume: 83

Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinogenesis; Caspase 3; Cell Differentiation; Colorectal Neoplasms; Cytokines; Disease Progression; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Macrophages; Mice; Mice, Nude; Naltrexone; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Opioid; Signal Transduction; Th1 Cells

2020